Azacitidine–Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells
Anticancer Research · 2024
DOI: 10.21873/anticanres.16898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Kuan-Ming Lai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Azacitidine, Leukemia, Myeloid, Acute, Hesperidin.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, R.O.C.
- Hemato-Oncology Division Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, R.O.C.
- Hematology & Oncology Research Laboratory, Changhua Christian Hospital, Changhua, Taiwan, R.O.C. 181550@cch.org.tw.
Zitieren
APA
Lai, K. M., Tseng, R. H., Shih, Y. H., & Huang, Y. C. (2024). Azacitidine–Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16898
Vancouver
Lai KM, Tseng RH, Shih YH, Huang YC. Azacitidine–Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells. Anticancer Research. 2024. doi:10.21873/anticanres.16898
BibTeX
@article{Lai2024,
author = {Lai, Kuan-Ming and Tseng, Ruo-Han and Shih, Yu-Hung and Huang, Ying-Chih},
title = {Azacitidine–Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16898}
}
EUVIMED